Neoadjuvant Immunotherapy Combined Chemotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Study

BACKGROUND: Combination of neoadjuvant immunotherapy and chemotherapy (nICT) is a novel treatment for locally esophageal cancer squamous cell carcinoma (ESCC). This study aimed to evaluate the potential effect of nICT on surgery safety by comparing short-term outcomes between the surgery alone group...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Zhi-Nuan, Weng, Kai, Peng, Kaiming, Chen, Zhen, Lin, Jihong, Kang, Mingqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712481/
https://www.ncbi.nlm.nih.gov/pubmed/34970498
http://dx.doi.org/10.3389/fonc.2021.797426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712481/
https://www.ncbi.nlm.nih.gov/pubmed/34970498
http://dx.doi.org/10.3389/fonc.2021.797426

Ejemplares similares